Article Details
Retrieved on: 2017-12-29 04:51:42
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>In September, 23andMe raised $250 million in a financing round led by <b>Sequoia</b> <b>Capital</b>. This weight loss study reflects the company's push to identify genetic determinants of chronic conditions, cancer, immunological disorders and skin diseases as part of an effort to refine its genomic tests and bring in ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here